C Calvo-González, J Reche-Frutos, J Donate- … - British Medical Journal, 2008 - bjo.bmj.com Articles on similar topics can be found in the following collections ... C
Calvo-González, 1 J Reche-Frutos, 1 J Donate-López, 1 J Garcıá, 1 M Leila, 2 ... C Fernández-Pérez, 1 J Garcia-Sánchez 1 Cited by 2 - Related articles - BL Direct - All 3 versions
S Wolf - Japanese Journal of Ophthalmology, 2008 - Springer Discovery of the involvement of VEGF in a number of pathologic conditions,
including neovascular age-related macular degeneration (AMD), diabetic
retinopathy, and cancer, has prompted the development of several anti- VEGF ... Cited by 3 - Related articles - All 4 versions
- ►duanessolution.com A NAVEA, J MATAIX, MC DESCO, M GARCIA … - Retina, 2009 - journals.lww.com Compared with initial vision, 79.3% of the eyes had the same or better vision
and 95.2% lost fewer than 15 letters. The total number of PDT treatments was 92
(a mean of 1.46 treatments per patient). The mean number of Bevacizumab ... Cited by 1 - Related articles - All 7 versions
RF SPAIDE, J Sorenson, L Maranan - Retina, 2005 - journals.lww.com 0.007, respectively), but at the end of the 12-month follow-up period, the mean
visual acuity was slightly worse than 20/40 (mean logMAR ... The only proven
therapy for extrafoveal and jux- tafoveal choroidal neovascularization is ... Cited by 44 - Related articles - BL Direct - All 3 versions
FB Aggio, GB Melo, AL Höfling-Lima, FM Eid - Acta Ophthalmologica Scandinavica, 2006 - ncbi.nlm.nih.gov 1: Acta Ophthalmol Scand. 2006 Dec;84(6):831-3. Photodynamic therapy with
verteporfin combined with intravitreal injection of bevacizumab ... Cited by 9 - Related articles - BL Direct - All 3 versions
AA Moshfeghi, CA Puliafito - Expert Opin. Investig. Drugs, 2005 - informahealthcare.com This article reviews pegaptanib sodium, a compound developed by Eyetech
Pharmaceuticals Inc. and Pfizer Inc., for the treatment of neovascular age-
related macular degeneration (AMD). Traditional treatment approaches to ... Cited by 25 - Related articles - BL Direct - All 4 versions
S MARKABI - RETINA, 2009 - journals.lww.com For a combination regimen to receive regulatory approval, it must provide some
incre- mental advantage over a previous standard. Although this advantage is
typically a greater likelihood of achieving a clinically relevant endpoint, ... Related articles - All 2 versions
[CITATION] The PIER Study Group. Randomized, double-masked, sham-controlled trial of ranibizumab …
AJ Augustin, U Schmidt-Erfurth - European Journal of Ophthalmology, 2006 - augenaerzte-baden-baden.de PURPOSE. Choroidal neovascularization associated with age-related macular
degeneration is the primary cause of blindness in the elderly in developed
countries, due to a number of pathogenic effects, including angiogenesis, ... Cited by 11 - Related articles - View as HTML - BL Direct - All 8 versions
F Source, R Methodology - Group, 2005 - evidence-based-eyecare.com Research Objective To compare the treatment effect and safety of photodynamic
therapy with verteporfin using a standard (SF) or re- duced (RF) light fluence
rate with that of placebo therapy in patients with sub- foveal minimally ... Related articles
